Silverback Therapeutics SBTX
€ 5.83
4.99%
Quartalsbericht 2024-Q3
hinzugefügt 13.11.2024
Silverback Therapeutics Bilanz 2011-2024 | SBTX
Bilanz Jährlich Silverback Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-70.7 M | -210 M | -59.4 M | -383 M | 5.64 M | -12.4 M | - | - | - | - | - | - | - |
Langfristige Schulden |
37 K | 251 K | 480 K | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
237 K | 230 K | 144 K | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 2.33 M | 56.5 M | 57.4 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
2.39 M | 5.44 M | 8.19 M | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
2.43 M | 8.55 M | 16.7 M | 11.9 M | 74.4 M | 62.5 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | 283 K | 1.46 M | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-131 M | -76.9 M | -42.3 M | -96.7 M | -63.8 M | -39.8 M | - | - | - | - | - | - | - |
Vermögenswerte |
233 M | 281 M | 61.4 M | 395 M | 15.6 M | 27.5 M | - | - | - | - | - | - | - |
Zahlungsmittel |
71 M | 211 M | 60.1 M | 387 M | - | - | - | - | - | - | - | - | - |
Buchwert |
231 M | 273 M | 44.8 M | 383 M | -58.8 M | -35 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
231 M | 273 M | -31.3 M | 383 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Silverback Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | 37 K | 92 K | 146 K | 199 K | 251 K | - | 4.06 M | 4.43 M | 4.76 M | 5.08 M | 1.78 M | 2.06 M | 2.33 M | 2.33 M | 2.33 M | 2.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
16.6 M | 6.72 M | 3.72 M | 2.43 M | 11.3 M | 10.2 M | 10 M | 8.55 M | 3.99 M | 15.2 M | 19.2 M | 19.7 M | 20.4 M | 17.3 M | 13.6 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | 10 K | 283 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-173 M | -154 M | -142 M | -131 M | -124 M | -109 M | -91.9 M | -76.9 M | -248 M | -230 M | -211 M | -186 M | -163 M | -140 M | -116 M | -96.7 M | -96.7 M | -96.7 M | -96.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
218 M | 222 M | 228 M | 233 M | 249 M | 259 M | 271 M | 281 M | 271 M | 294 M | 312 M | 333 M | 353 M | 367 M | 382 M | 395 M | 395 M | 395 M | 395 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
39.7 M | 36.6 M | 56 M | 71 M | 60.5 M | 119 M | 87.9 M | 211 M | 37.3 M | 44.6 M | 52.2 M | 254 M | 301 M | 360 M | 374 M | 387 M | 387 M | 387 M | 387 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
201 M | 215 M | 224 M | 231 M | 237 M | 249 M | 261 M | 273 M | 267 M | 279 M | 293 M | 314 M | 332 M | 350 M | 369 M | 383 M | 383 M | 383 M | 383 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
201 M | 215 M | 224 M | 231 M | 237 M | 249 M | 261 M | 273 M | -50.2 M | -44 M | -38.3 M | 314 M | 332 M | 350 M | 369 M | 383 M | 383 M | 383 M | 383 M | -58.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung